Elderly men's quality of life and lower urinary tract symptoms: an intricate relationship by Pintarelli, Vitor Last et al.
758
Elderly Men’s Qol and Luts
ABSTRACT
Purpose: To evaluate the impact of lower urinary tract symptoms (LUTS) on the quality of life (QoL) in a group of 
elderly men.
Materials and Methods: Observational clinical study contained 200 men recruited between March-September 2008 in the 
community and Urology and Geriatrics ambulatories. The data collected included health and sociodemographic condi-
tions; the International Prostate Symptom Score (IPSS); an anxiety/depression inventory; the World Health Organiza-
tion Quality of Life -Bref and -Old questionnaires (WHOQoL). Participants were classified according to IPSS: Group I 
(moderate/severe symptoms) and Group II (absence/mild symptoms) and 100 men were included in each group. Results: 
The groups were statistically similar in sociodemographic, morbidity, and anxiety/depression scores. Both QoL scales 
showed significant lower median scores in group I in all parameters, except the global subjective self-evaluation of QoL. 
The domains social and environmental relations presented the most significative differences (p < 0.0005) in both ques-
tionnaires, and final mean  WHOQoL-Old score was lower in group I (p < 0.0005).
Conclusions: For elderly men, moderate to severe LUTS do significantly impact almost all parameters of QoL proposed 
by the WHO, especially social and environmental relations.
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INTRODUCTION
 The conditions leading to lower urinary tract 
symptoms (LUTS) are among the most prevalent dis-
eases of elderly males, with potential impairment of 
quality of life (QoL) (1-11). Among elderly men, be-
nign prostatic enlargement (BPE) is the main cause 
of LUTS, which can be evaluated by the Internation-
al Prostate Symptom Score (IPSS) (1-3,12). Among 
elderly men, benign prostatic enlargement (BPE) is 
the main cause of LUTS. Despite criticisms about 
its discriminatory power to predict infravesical ob-
struction, the International Prostate Symptom Score 
(IPSS) is the most used instrument to evaluate LUTS 
in male patients (1-3,13). BPE, except in extreme 
cases, does not pose a major threat to one’s physi-
cal integrity, but undermines QoL; for most mild and 
moderate-symptom patients, QoL impairment is the 
main parameter evaluated on whether treating BPE, 
and choosing therapeutic methods (1-13). Many ar-
ticles attempting to evaluate the impact of LUTS and 
BPE on men’s QoL have been published since the 
World Health Organization Consensus Committee 
recommended the association of the IPSS with QoL 
scales, but inappropriate interpretations of the con-
cept of QoL in many of these studies have triggered 
criticisms (3,14-17). Furthermore, while BPE occurs 
predominantly in elderly men, and validated geriat-
ric QoL scales do exist, no studies using such ques-
tionnaires to assess the impact of LUTS on elderly 
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populations have been published. This article aims to 
assess the role of LUTS on the QoL in a group of el-
derly men.
MATERIALS AND METHODS
This was an observational clinical study con-
ducted between March-September 2008, approved by 
the institutional ethics committee.
The inclusion criteria were: male sex; 65-years 
aged or over; voluntary participation; understanding 
and signing the consent form. The exclusion criteria 
were: previous radical prostatectomy; use of bladder 
catheter; acute diseases; trauma, surgeries or hospital-
izations during the preceding month; uncompensated 
chronic diseases; malignancies; neuropsychiatric dis-
eases; alcoholism; drug abuse; use of psychotropics. 
Two hundred men (any race, schooling and social lev-
el) were selected from among Urology (90 patients) 
and Geriatrics (60) outpatients at a university hospital, 
these patient’s companions (10), participants of com-
munity centers (20) and fitness programs for the el-
derly (20). The research protocol was composed of:
1. Sociodemographic and health conditions 
questionnaire;
2. International Prostate Symptom Score 
(IPSS) (14);
3. Hospital Anxiety and Depression Scale 
(HADS) (18);
4. WHOQoL-Bref questionnaire (19);
5. WHOQoL-Old questionnaire (20);
Four trained researchers conducted the inter-
views in private rooms, which lasted on average 40 
minutes. Self-administration of questionnaires was 
preferred, but face-to-face interviews were conducted 
when the participants presented visual deficits, illit-
eracy or semi-illiteracy. Only 13 participants could not 
respond by themselves.
Sociodemographic information included age, 
race, marital status, schooling, religion, economic and 
employment status. Health conditions investigated 
included previous diagnoses of hypertension, diabe-
tes and heart diseases; use of medications; practice of 
sports or physical activities (at least walking for 30 
minutes, thrice a week).
The Hospital Anxiety and Depression Scale 
(HADS), also used to evaluate non-hospitalized pa-
tients and individuals without disease, has 14 items, 
seven focusing on anxiety assessment (HADS-A), 
and seven on depression (HADS-D). Each of its 
items can be scored from 0-3, giving a maximum 
score of 21 points for each scale. Values ≥ 9 posi-
tively detect the assessed symptom (18).
 The questionnaires WHOQoL-Bref and 
WHOQoL-Old are generic instruments developed 
by the World Health Organization to evaluate quality 
of life (QoL) with cross-cultural validity and applica-
bility. Both provide a comprehensive assessment of 
QoL through evaluating different parameters (termed 
domains and facets), such as physical health, psy-
chological aspects, social relationships, among oth-
ers. The questionnaire WHOQoL-Bref contains 26 
multiple-choice questions, divided in four domains. 
The questionnaire WHOQoL-Old was especially de-
veloped to assess individuals aged 60-years or over, 
and contains 24 multiple-choice questions, divided 
in six facets. In both questionnaires, the scores from 
responses produce a profile of QoL, which can be 
split into individual scores, for each of the different 
domains and facets examined, scaled in a positive 
direction (higher scores indicate higher QoL); the 
average scores from items within each field are used 
to calculate the score for the whole field, and, for the 
questionnaire WHOQoL-Old, an overall score can 
be calculated (19,20).
The participants were divided into two 
groups, according to the IPSS results:
Group I: Scores 8-35 (moderate/severe 
symptoms).
Group II: Scores 0-7 (absence/mild symp-
toms). 
The sample size was estimated from a pi-
lot sample, composed of the first 50 participants in 
each group. The loss of, in mean, 1 point per facet 
of the WHOQoL-Old questionnaire was accepted 
as clinically significant; assuming a difference of 
6.5 units as relevant, with standard deviation of 
14, statistical analysis estimated that a sample of 
100 participants per group would be needed for 
the detection of statistically significant differences 
between the mean total scores of WHOQoL-Old 
for the two groups (assuming a statistical power 
of 90% and a significance level of 5%), through a 
bilateral hypothesis test. For statistical evaluation, 
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the tests used were student’s t, Brown-Mood, chi-
square, and Fisher-Freeman-Halton exact test.
Every significant probability (p values) was 
recorded as the bilateral type, and values < 0.05 
were considered statistically significant. The SAS 
9.1 software (Statistical Analysis System, Cary, 
NC, USA) and Minitab 14.1 (State College, PA, 
USA) were used for the statistical analyses.
RESULTS
The results from the sociodemographic and 
health conditions data are described in Table-1.
Mean ages were 72.89 (± 5.96) and 73.41 
(± 5.95) years, in groups I and II, respectively (p = 
0.538). The distribution of proportions of race cat-
egories (p = 0.0932), schooling level (p = 0.1521), 
and diagnoses of hypertension (p = 0.099), diabetes 
(p = 0.5993), heart diseases (p = 0.6418) and seden-
tarism (p = 0.1543), marital status (p = 0.5127), reli-
gious denominations (p = 0.4079), monthly income (p 
= 0.9848), causes of inactivity (p = 0.9446) and use of 
medications (p = 0.4306) showed no difference.
With regard to HADS scores, the number of 
individuals who attained the anxiety and depression 
cutoff scores was exactly the same, 21 men in group 
Table 1 - Main socio-demographic and health conditions results.
Socio-demographic and health data Group I Group II Total
Age 65-69 years-old 35 30 65 (32.5%)
70-79 years-old 48 50 98 (49.0%)
≥ 80 years-old 17 20 37 (18.5%)
Minimum 65 65
Maximum 88 89
Median 72.5 72.5
Mean (SD) 72.89 (± 5.96) 73.41 (± 5.95)
Ethnicity / race White 70 74 144 (72.0%)
Non-white 30 26 56 (28.0%)
Marital status Married 74 82 156 (78.0%)
Widowed 13 11 24 (12.0%)
Religion Catholics 75 71 146 (73.0%)
Protestants 16 13 29 (14.5%)
Schooling Primary school 78 66 144 (72.0%)
Monthly income ≤ 2 MW 48 44 92 (46.0%)
2-5 MW 43 47 90 (45.0%)
Inactivity causes Retirement 73 70 143 (71.5%)
Still active 23 24 47 (23.5%)
Arterial hypertension 72 61 133 (66.5%)
Diabetes mellitus 22 19 41 (20.5%)
Heart diseases 31 28 59 (29.5%)
Anti-hypertensive drugs use 55 47 102 (46.0%)
Anti-diabetic drugs use 02 03 05 (2.5%)
Anti-hypertensive and anti-diabetic drugs use 17 14 31 (15.5%)
Sedentary 61 51 112 (56.0%)
SD: standard deviation; MW: minimum wages (About US$ 200.00).
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I and 8 in group II, for each of these conditions, lead-
ing to no differences in the proportions of anxiety (p 
= 0.0932) and depression scores (p = 0.0932).
 Groups I and II presented mean IPSS 15.83 
(± 6.3) and 4.01 (± 2.12) respectively. The medians 
for IPSS-QoL were also different between the two 
groups (p < 0.0001).
The WHOQoL-Bref scores achieved for 
each question were transformed into a scale of one 
hundred points, in accordance with the syntax rec-
ommended in the manual. The statistical analysis 
on these responses was performed by gathering the 
questions relating to every QoL domain evaluated. 
Such results are presented in Tables 2 and 3.
The first two questions of the WHOQoL-
Bref presented significant differences in responses 
only in the second question (p < 0.0001), however 
the means scores from each WHOQoL-Bref domain 
revealed differences between the scores of: physi-
cal health (p = 0.007), psychological aspects (p = 
0.001), social relationships (p < 0.0005) and envi-
ronment (p < 0.0005).
Table 2 - WHOQoL-BREF Results Relative to the First Two Questions.
Questions Answers Group I Group II Total p
1. How would you rate your quality 
of life?
Very poor 01 01 02 (1.0%) 0.0814
Poor 04 01 05 (2.5%)
Neither good nor poor 29 20 49 (24.5%)
Good 62 66 128 (64.0%)
Very good 04 12 16 (8.0%)
Total 100 100 200 (100%)
2. How satisfied are you with your 
health?
Very dissatisfied 03 00 03 (1.5%) < 0.0001
Dissatisfied 20 05 25 (12.5%)
Neither satisfied nor 
dissatisfied
28 16 44 (22.0%)
Satisfied 41 58 99 (49.5%)
Very satisfied 08 21 29 (14.5%)
Total 100 100 200 (100%)
Table 3 - WHOQoL-BREF Results Relative to the Four Domains.
Domain Values Group I Group II p
Physical health Mean (SD) 56.5 (± 10.2) 60.32 (± 9.36) 0.007
Standard error 1.0 0.94
Psychological Mean (SD) 56.2 (± 12.0) 61.5 (± 10.0) 0.001
Standard error 1.2 1.0
Social relationships Mean (SD) 62.3 (± 16.5) 70.4 (± 14.4) < 0.0005
Standard error 1.7 1.4
Environment Mean (SD) 57.0 (± 12.2) 65.5 (± 12.7) < 0.0005
Standard error 1.2 1.3
SD: Standard deviation
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WHOQoL-Old scores were transformed in 
accordance with the syntax in the manual, to com-
pare the mean scores of every facet and produce the 
overall WHOQoL-Old score. The results relating to 
WHOQoL-Old scores are presented in Table-4.
The analysis of mean scores of the question-
naire WHOQoL-Old revealed differences between 
the scores obtained by groups I and II for each of 
the six facets, and also for the final score: sensory 
functioning (p = 0.003), autonomy (p = 0.003), past, 
present and future activities (p = 0.001), social par-
ticipation (p < 0.0005), dying and death (p = 0.003), 
intimacy (p = 0.003) and Old score (p < 0.0005).
DISCUSSION
The variety of backgrounds of participants 
was adopted to raise the epidemiological spectrum 
of the sample, so as not to restrict the investigation to 
patients undergoing outpatient medical care. How-
ever, it should be mentioned that this was not a true 
random sample of men, but patients were chosen for 
inclusion into the study, which allows the possibility 
of selection bias. The exclusion criteria were, essen-
tially, prevalent clinical conditions that undermine 
QoL. Previous radical prostatectomy was an exclu-
sion criterion because it is mainly used as treatment 
for prostate malignancies.
Users of bladder catheters were excluded be-
cause of the impossibility to assess LUTS through 
the IPSS. Previous transurethral resection of pros-
tate, except for recent postoperative states, and the 
use of alpha-blockers and 5-alpha-reductase inhibi-
tors, were not exclusion criteria, because neither pre-
vent assessment of LUTS, nevertheless symptoms 
at the time of the interview could be different from 
those observed before such treatments.
 The two groups were adequately matched to 
sociodemographic and health condition. Despite not 
statistically significant, a trend to increase in anxi-
ety and depression scores was observed in group I. 
The median age was similar in the two groups (72.5 
years); nevertheless it could seem a low indicator for 
a geriatric sample, it exceeds the 2006 WHO estima-
tive of male population life-expectancy of this coun-
try (68.8 years), and overlaps in more than 12 years 
Table 4 - WHOQoL-OLD Results.
Facet Values Group I Group II p
Sensory Functioning Mean (SD) 14.71 (± 3.55) 15.68 (± 3.17) 0.003
Standard error 0.35 0.32
Autonomy Mean (SD) 14.24 (± 2.68) 15.38 (± 2.58) 0.003
Standard error 0.27 0.26
Past, Present and Future 
Activities
Mean (SD) 14.03 (± 2.83) 15.26 (± 2.42) 0.001
Standard error 0.28 0.24
Social Participation Mean (SD) 13.77 (± 2.69) 15.10 (± 2.44) < 0.0005
Standard error 0.27 0.24
Dying and Death Mean (SD) 14.49 (± 4.01) 16.12 (± 3.69) 0.003
Standard error 0.40 0.37
Intimacy Mean (SD) 15.09 (± 2.94) 16.27 (± 2.67) 0.003
Standard error 0.29 0.27
Final global score OLD Mean (SD) 86.3 (± 12.5) 93.8 (± 11.5) < 0.0005
Standard error 1.3 1.1
SD: Standard deviation
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the 60-year-old parameter, accepted in developing 
countries as demographic indicator for classification 
of elderly people.
 Most of the studies performed to measure the 
impact of LUTS on men’s QoL evaluate pharmaco-
logical and surgical treatments for BPO, and largely 
adopt expressions like “quality of life” and “health-
related quality of life”, since most of the authors be-
lieve that the impairment of QoL due to LUTS is a 
key measurement to assess the effectiveness of any 
treatment for BPO (1-11,17,21). However, criticisms 
have been made regarding the poor standardization 
of QoL scales, and the frequent inappropriate use of 
the term QoL (17). The use of a one-item scale to 
assess general QoL (the IPSS-QoL question, called 
“bother score”), and the misinterpretation of QoL as 
synonym of symptom-control, or perceived general 
health or functional status, are the most frequent rea-
sons for such criticisms (1,9,17,21).
 In the present study, two QoL scales vali-
dated by the WHO (one especially developed to 
assess the geriatric population) were used (19,20). 
Over the last ten years, despite descriptions of as-
sociations between LUTS and advancing age, with 
increasing discomfort, impairment of daily activities 
and perception of poor health, few texts were specifi-
cally focused on elderly men, and none adopted the 
WHOQoL-Old (3,5,22).
 All domains and facets evaluated by both 
QoL questionnaires, with the exception of the first 
question of WHOQoL-Bref, reached results that 
differed statistically between the two groups, with 
lower QoL scores in group I. The items assessed by 
WHOQoL-Bref with lower p value (p < 0.0005) were 
observed in the domains “social relationships”, “en-
vironment”, and the question “self-satisfaction with 
his own health” (p < 0.0001). Among WHOQoL-
Old results, the facet “social participation” and the 
Old score presented the lowest p values (< 0.0005). 
These results can be compared with the findings of 
two studies that applied the SF-36 questionnaire to 
men with LUTS and/or BPE. In the first study, the 
IPSS and SF-36 were used to evaluate 189 patients 
on the waiting list for surgical treatment for BPE, 
who presented worse perceptions of QoL than the 
general population of similar age, in direct relation to 
increasing severity of irritative symptoms (7). Social 
functioning was the parameter of best performance, 
and role-physical was the worst one. The second 
study employed the SF-36 and the American Uro-
logical Association Symptom Index, and the main 
losses of QoL were in energy and vitality, general 
health perception and overall physical dimension 
(10). Significant worsening of social functioning of 
individuals with LUTS was not identified, and the 
authors reasoned this result might have been due to 
inadequacy of the SF-36 for recognizing the social 
impact caused by LUTS. Besides such studies evalu-
ated men whose mean age was 68.8 ± 6.9 and 61.9 ± 
9.1 years, none was designed to evaluate a geriatric 
population.
 Another study evaluated 480 men referred 
for urological consultation, using the WHOQoL-
Bref and the IPSS (23). There was no exclusive se-
lection of elderly patients, and the only QoL domain 
impaired by increasing LUTS was physical health. 
Such article concludes that WHOQoL-Bref would be 
too comprehensive to identify associations between 
specific symptom-related factors, and LUTS sugges-
tive of BPE and LUTS-associated factors would not 
be important determinants of QoL.
 The present study signals that older men 
are particularly sensitive to the impact of LUTS on 
their QoL, because all domains and facets of QoL 
analyzed by WHOQoL-Bref and WHOQoL-Old had 
significantly lower scores among moderate to se-
vere-symptomatic patients. These findings corrobo-
rate for the existence of important QoL indicators for 
the elderly, which are not evaluated on general QoL 
scales for adults; studies that make no distinction be-
tween different age groups may be unable to recog-
nize differences in QoL impairment related to age. 
Additionally, older men’s perceptions of the impact 
of LUTS on their QoL extend not only to parameters 
straightly determined by urinary symptoms. Mem-
bers of group I presented worse performances in sen-
sory functioning and perception of death and dying, 
which do not seem to have any direct/causal relation-
ship with LUTS. The psychological impact of LUTS 
on elderly men might lead to poor self-perception of 
QoL, and group I members did present lower scores 
in psychological domains, while LUTS-related psy-
chological aspects have already been described else-
where (24,25). However, in the present study, similar 
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scores for depression and anxiety were recorded for 
the two groups. Hence, whether self-depreciation of 
QoL is cause or consequence of LUTS-related psy-
chological factors can not be described here.
 Finally, this study leads to reflections on the 
importance of proper assessment of moderate LUTS 
men. Group I joined moderate and severe LUTS pa-
tients, but its mean IPSS was 15.83 (± 6.3), which 
suggests that the results could be extrapolated for 
moderate symptomatic patients. Surgical treatments 
are predominantly indicated for severe-symptom-
atic patients, and watchful waiting or conservative 
measures are indicated for patients with mild com-
plaints (2,14,26). However, therapeutic choices for 
moderate cases are frequent source of doubts among 
urologists, especially in the presence of co-morbidi-
ties. Recognition of significant deterioration of QoL 
among moderate LUTS patients is an evidence for 
the need of treatment (as opposed to waiting ap-
proaches), and justification for early surgery (26).
 The similarity of answers to the self-rated 
QoL question (WHOQoL-Bref n.1) only represents 
an apparent contradiction. The answers to 49 of 50 
questions that compose the two QoL questionnaires 
presented lower scores in group I, besides around 
90% of all participants declared that their QoL was 
“good” or “neither bad nor good”. This inconsis-
tency exemplifies that a single question for QoL as-
sessment may not reflect the results obtained with 
comprehensive scales (17).
In regards to potential problems and limita-
tions, the population studied was not a true random 
sample of elderly men, which allows the possibility 
of selection bias. The role of specific comorbities, 
the analysis of age subgroups, and clinical impli-
cations of the results obtained were not evaluated. 
Potential differences between moderate and severe 
LUTS patients could not be determined precisely, 
because they were joined in the same group.
CONCLUSIONS
 Men aged 65-years or over with moderate/
severe LUTS have worse QoL ratings for almost 
all evaluation parameters proposed by the World 
Health Organization, according to the WHOQoL-
Bref and WHOQoL-Old instruments, especially 
social and environmental relationships, compared 
with mildly symptomatic or asymptomatic men in 
the same age group.
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ABBREVIATIONS
BPE - Benign prostatic enlargement
CI - Confidence interval
HADS - Hospital Anxiety and Depression Scale
IPSS - International Prostate Symptom Score
LUTS - Lower urinary tract symptoms
MW - Minimum wages
QoL - Quality of life
SD - Standard deviation
WHO - World Health Organization
WHOQoL - World Health Organization Quality of 
Life
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